This section of the website is for patients who have been prescribed IQIRVO® (elafibranor) in the UK. Information for members of the general public can be found here.

This medicine is subject to additional monitoring. This will allow quick identification of new safety information. You can help by reporting any side effects you may get. Reporting of side effects. If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. You can also report side effects directly via the Yellow Card Scheme at https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in Google Play or Apple App Store. Side effects should also be reported to Ipsen via email at pharmacovigilance.uk-ie@ipsen.com or phone 01753 627777. By reporting side effects, you can help provide more information on the safety of this medicine.

Patient Support

Primary Biliary Cholangitis (PBC)

 

For full information, please refer to the patient information leaflet that came with the medication.
Should you have further questions and/or concerns about your treatment or about your condition, please speak with your healthcare professional.

Information about your medicine

Understanding PBC

Living with PBC